Surgical Science Sweden AB (publ)
SUSRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $8,202 | $6,078 | $8,538 | $12,289 |
| - Cash | $968 | $634 | $434 | $317 |
| + Debt | $57 | $40 | $15 | $12 |
| Enterprise Value | $7,291 | $5,484 | $8,119 | $11,984 |
| Revenue | $884 | $883 | $803 | $367 |
| % Growth | 0.1% | 10% | 118.8% | – |
| Gross Profit | $598 | $613 | $532 | $266 |
| % Margin | 67.6% | 69.4% | 66.2% | 72.5% |
| EBITDA | $170 | $214 | $271 | $115 |
| % Margin | 19.2% | 24.3% | 33.8% | 31.4% |
| Net Income | $132 | $234 | $188 | $86 |
| % Margin | 14.9% | 26.5% | 23.4% | 23.5% |
| EPS Diluted | 2.58 | 4.59 | 3.69 | 2.02 |
| % Growth | -43.8% | 24.4% | 82.7% | – |
| Operating Cash Flow | $137 | $238 | $129 | $39 |
| Capital Expenditures | -$48 | -$44 | -$35 | -$14 |
| Free Cash Flow | $90 | $194 | $95 | $25 |